BALAJI AMINES LIMITED

Manufactures a range of amines and specialty chemicals — including ethylenediamine-based products (DETA, TETA, PIP, AEEA, AEP), N-methyl morpholine, acetonitrile, hydrogen cyanide, sodium cyanide, EDTA, dimethyl ether (DME) and battery-grade chemicals — selling primarily to pharmaceutical, agrochemical, solvents and battery industries. The Amines & Speciality Chemicals segment brought in Rs 1,415.69 crore of revenue in the period to 31 March 2026 (97.1% of segment revenue), with EBIT of Rs 225.25 crore. A separate Hotel Division contributed Rs 35.70 crore (2.4% of segment revenue) and EBIT of Rs 9.37 crore. Operations run across 6 manufacturing plants serving 55 countries, with exports at 14.3% of the business. India's first commercial 100,000 TPA DME plant was commissioned in Q1 FY27, a 5,000 TPA N-methyl morpholine expansion is in progress, and subsidiary Balaji Specialty Chemicals is executing a Rs 750 crore phased build-out (Unit-I for EDA-based products in H1 FY27; Unit-II for HCN, NaCN, EDTA in Q4 FY27). Raw materials are the dominant cost at 56.9% of revenue, followed by other operating expenses at 19.6% and employee costs at 5.9%.